Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CD8 co-receptor modulates the specificity profile of the 1G4 TCR against NY-ESO-1

Molecular Therapy(2025)10.1016/j.ymthe.2025.10.006Source: DataRank Database

CD8 co-receptor modulates the specificity profile of the 1G4 TCR against NY-ESO-1 is a research paper published in Molecular Therapy (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 0.00)OA: greenTopics (45)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Zita E. H. Aretz ORCID,Ron S. Gejman ORCID,Tara Cicic,David A. Scheinberg ORCID,Heather F. Jones ORCID

Live enrichment

PubMed:41058174 OpenAlex:https://openalex.org/W4414919926

National Institutes of Health

Grant: R35 CA241894

National Institutes of Health

Grant: RO1 CA55349

National Institutes of Health

Grant: PO1 CA23766

National Cancer Institute

Grant: F31 CA253995

National Cancer Institute

Grant: F30 CA200327

National Cancer Institute

Grant: P30 CA008748

National Institute of General Medical Sciences

Grant: T32GM07739

NCI NIH HHS

Grant: R01 CA055349

NCI NIH HHS

Grant: P01 CA023766

NIGMS NIH HHS

Grant: T32 GM007739

Commonwealth Foundation for Cancer Research Foundation

FWCI

0.00

Citation Percentile

0.3%

greenLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12590357/

publisherhttps://api.elsevier.com/content/article/PII:S1525001625008275?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001625008275?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ymthe.2025.10.006

Fields of Study

Cancer Immunotherapy and BiomarkersImmune cells in cancerChemokine receptors and signalingMedicineBiologyHumansAntigens, NeoplasmReceptors, Antigen, T-CellAnimalsMiceCD8-Positive T-LymphocytesMembrane ProteinsCD8 AntigensEpitopes, T-LymphocyteCD4-Positive T-LymphocytesCell Line, Tumor

MeSH Terms

AnimalsAntigens, NeoplasmHumansMembrane ProteinsReceptors, Antigen, T-CellCD4-Positive T-LymphocytesCD8 AntigensCD8-Positive T-LymphocytesEpitopes, T-LymphocyteCell Line, TumorMice

Keywords

EpitopeCD8Cytotoxic T cellT-cell receptorAntigenIn vitroT cellProteomeNY-ESO-1Cancer ImmunotherapyTcr-engineered T CellsT Cell SpecificityPresenterToxicity RisksCd8 And Cd4 RolesAffinity-enhanced TcrOff-target Reactivity1G4